VetDC and TANOVEA-CA1®

TANOVEA-CA1 is the first FDA conditionally approved drug for the treatment of canine lymphoma. While working with this client, I designed a variety of printed materials (banner ups, brochures, mailers, postcards, notepads, advertising campaigns), front-end website designs (full web page designs, banner images, small image callouts), and HTML5 email campaigns built in Mailchimp used to promote TANOVEA-CA1 to pet parents and vets.